Empagliflozin improves diastolic function in a nondiabetic rodent model of heart failure with preserved ejection fraction
KA Connelly, Y Zhang, A Visram, A Advani… - JACC: Basic to …, 2019 - jacc.org
Recent studies send an unambiguous signal that the class of agents known as sodium-
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
[HTML][HTML] Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
KA Connelly, Y Zhang, A Visram, A Advani… - JACC: Basic to …, 2019 - Elsevier
Recent studies send an unambiguous signal that the class of agents known as sodium-
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
KA Connelly, Y Zhang, A Visram… - JACC. Basic to …, 2019 - pubmed.ncbi.nlm.nih.gov
Recent studies send an unambiguous signal that the class of agents known as sodium-
glucose-linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
glucose-linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
[HTML][HTML] Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
KA Connelly, Y Zhang, A Visram, A Advani… - JACC: Basic to …, 2019 - ncbi.nlm.nih.gov
Recent studies send an unambiguous signal that the class of agents known as sodium-
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction.
KA Connelly, Y Zhang, A Visram, A Advani… - JACC. Basic to …, 2019 - europepmc.org
Recent studies send an unambiguous signal that the class of agents known as sodium-
glucose-linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
glucose-linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction.
KA Connelly, Y Zhang, A Visram, A Advani… - JACC. Basic to …, 2019 - europepmc.org
Recent studies send an unambiguous signal that the class of agents known as sodium-
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …
glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in …